CIK 0001570562
- Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 461385614
- Phone
- +1 949-284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Open-market buy Director bought 20,000 shares at $9.45 ($189,000)
- 4 Planned sale See Remarks sold 3,385 shares at $9.87 ($33,397)
- 4 Planned sale Chief Financial Officer sold 6,494 shares at $10.02 ($65,070)
- 4 Planned sale See Remarks sold 15,787 shares at $9.87 ($155,756)
- 4 Planned sale See Remarks sold 6,251 shares at $12.40 ($77,512)
- 4 Planned sale See Remarks sold 27,904 shares at $13.26 ($369,868)
- 4 Planned sale Chief Financial Officer sold 8,996 shares at $13.26 ($119,243)
- 4 Planned sale Chief Marketing Officer sold 4,536 shares at $13.26 ($60,125)
- 4 Planned sale See Remarks sold 103,376 shares at $13.26 ($1,370,249)
- 4 Open-market sale Director sold 12,888 shares at $12.99 ($167,465)
- 4 Grant or award Chief Marketing Officer acquired 17,832 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 35,663 shares (grant or award)
- 4 Grant or award See Remarks acquired 95,399 shares (grant or award)
- 4 Grant or award See Remarks acquired 23,776 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
- 4 Grant or award Director acquired 7,364 shares (grant or award)
Page 2 of 13 · 252 filings